Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety and Efficacy Surveillance of Motherwort Injection : a Registry Study

NCT06636422 is registered in ClinicalTrials.gov with Zhong Wang as lead sponsor.

NCT NCT06636422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06636422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection : a Registry Study
Lead sponsor
Zhong Wang
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2024
Completion date
October 15, 2025
Enrollment
20,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse events, bleeding, real-world study